FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

373692009: Substance with phosphodiesterase inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1212151018 Phosphodiesterase inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3520795018 Substance with phosphodiesterase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3520964015 Substance with phosphodiesterase inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

38 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with phosphodiesterase inhibitor mechanism of action Is a Inotropic agent false Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Is a Substance with hydrolase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Has disposition Phosphodiesterase inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Milrinone Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phosphodiesterase inhibitor poisoning Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Accidental phosphodiesterase inhibitor poisoning Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Intentional phosphodiesterase inhibitor poisoning Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phosphodiesterase inhibitor poisoning of undetermined intent Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 2
Phosphodiesterase inhibitor adverse reaction Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Allergy to phosphodiesterase inhibitor Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phosphodiesterase inhibitor overdose Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Accidental phosphodiesterase inhibitor overdose Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Intentional phosphodiesterase inhibitor overdose Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Phosphodiesterase inhibitor overdose of undetermined intent Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Product containing phosphodiesterase inhibitor Has active ingredient True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Enoximone Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cilostazol Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with phosphodiesterase 5 inhibitor mechanism of action Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Amrinone Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 100 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 25mg/mL injection solution 10mL ampule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 225mg modified release tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 350mg modified release tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 100mg modified release tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 25mg/mL injection solution 10mL prefilled syringe Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine solution Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and ergotamine tartrate 2 milligram/1 each conventional release rectal suppository Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing xanthine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aminophylline in oral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aminophylline in parenteral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine 5mg/mL injection solution 2mL vial Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine and sodium benzoate injection solution vial Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aminophylline Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and dihydrocodeine tartrate and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Xanthine bronchodilators Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine and cinnamedrine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine and orphenadrine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and paracetamol and salicylamide Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing buffered aspirin and caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline 125mg/mL injection solution 2mL ampule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline 160mg/15ml elixir Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline 100mg/15mL Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely diprophylline 200 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine citrate 20mg/mL injection solution ampule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine citrate 20mg solution Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 30 milligram and dihydrocodeine tartrate 16 milligram and paracetamol 356.4 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 385 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 856 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline + guaifenesin 100mg/100mg elixir Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline + guaifenesin 100mg/100mg liquid Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline + guaifenesin 100mg/100mg syrup Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline + guaifenesin 100mg/50mg syrup Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely diprophylline 200 milligram and guaifenesin 100 milligram/1 each conventional release oral capsule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 25mg/mL injection solution 10mL vial Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 25mg/mL injection solution 10mL amp Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10mL injection 20mL ampule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing diprophylline Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aspirin + caffeine + orphenadrine citrate tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine in oral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine in rectal dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine in parenteral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline m/r tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aminophylline in rectal dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 250 milligram/1 each conventional release rectal suppository (clinical drug) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 200 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 105mg/5ml oral liquid Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing diprophylline in oral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing diprophylline in parenteral dose form (medicinal product form) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dyphylline + guaifenesin 300mg/300mg liquid Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and butalbital and caffeine and codeine phosphate Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and isometheptene mucate and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing diprophylline and guaifenesin Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine and propoxyphene hydrochloride Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and caffeine and dihydrocodeine tartrate Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine + ergotamine tartrate Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and sodium benzoate Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing butalbital and caffeine and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aspirin + caffeine + orphenadrine citrate Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing butalbital and caffeine and codeine phosphate and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing aspirin and butalbital and caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start